Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2026

世界の動物診断市場予測:製品別、技術別、動物別、エンドユーザー別

◆タイトル:Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2026
◆商品コード:MD2411
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年6月20日
◆ページ数:413
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は世界の動物診断市場規模が2021年25億ドルから2026年39億ドルまで、年平均9.4%成長すると予想しています。本市場調査レポートでは、動物診断の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品、機器)分析、技術別(免疫診断、臨床生化学、分子診断、血液、尿検査)分析、動物種類別(コンパニオンアニマル、家畜)分析、エンドユーザー別(獣医参照研究所、動物病院・クリニック、ポイントオブケア(POC)/院内検査、動物研究機関・大学)分析、地域別分析、競争状況、企業情報など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の動物診断市場規模:製品別(消耗品、機器)
・世界の動物診断市場規模:技術別(免疫診断、臨床生化学、分子診断、血液、尿検査)
・世界の動物診断市場規模:動物種類別(コンパニオンアニマル、家畜)
・世界の動物診断市場規模:エンドユーザー別(獣医参照研究所、動物病院・クリニック、ポイントオブケア(POC)/院内検査、動物研究機関・大学)
・世界の動物診断市場規模:地域別
・競争状況
・企業情報

“The veterinary diagnostics market is expected to reach USD 3.9 billion by 2026 from an estimated USD 2.5 billion in 2021, at a CAGR of 9.4%.”
Market growth can largely be attributed to the growth in the companion animal population, increasing incidence of transboundary and zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance, growing animal health expenditure, and growth in the number of veterinary practitioners and income levels in developed economies. On the other hand, rising petcare costs is expected to restrain the overall market growth. Currently, the lack of skilled veterinarians and diagnostic infrastructure, especially in developing countries, is one of the major factors limiting the uptake of advanced diagnostic solutions among veterinarians. The high cost of advanced diagnostic tests is another major barrier to its widespread adoption.

COVID-19—or coronavirus disease 2019—is the disease that people get from being infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Domestic animals do not get COVID-19 as humans do, but under natural conditions, pet cats—and, to a lesser extent, pet dogs—may, albeit rarely, become infected with SARS-CoV-2 after close and prolonged contact with a COVID-19-positive person. The number of vet visits and diagnostic testing drastically reduced in March, April, and May 2020 but started increasing from the third quarter of 2020 with a high growth rate. It is expected to normalize in the second and third quarters of 2021. Hence, the COVID-19 pandemic is expected to have a temporary and minimal impact on the veterinary diagnostics market during the forecast period.

“Consumables accounted for the highest share of the global veterinary diagnostics market in 2020”
Based on product, the global veterinary diagnostics market is segmented into instruments and consumables. In 2020, the consumables segment accounted for the largest share of the global veterinary diagnostics market. The large share of the consumables segment can be attributed to the recurrent purchase of diagnostic kits and reagents due to the increasing volume of diagnostic tests, increasing incidence of various infectious diseases, and increasing veterinary expenditure.

“Immunodiagnostics segment occupies the highest share in the global veterinary diagnostics market in the forecasted period”
Based on technology, the global veterinary diagnostics market is segmented into Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, and Other Veterinary Diagnostic Technologies. The large share of this segment can primarily be attributed to the widespread popularity of immunodiagnostics in disease diagnosis as well as in screening disease progression and observing patients’ responses to therapy. In addition, the low cost, low procedural complexity, and greater adoption of immunodiagnostics due to ease of training are further driving the growth of this market segment. Furthermore, the recurrent purchase of diagnostic kits and reagents due to the increasing volume of diagnostic tests, increasing incidence of various infectious diseases, and increasing veterinary expenditure is expected to increase growth. Additionally, the higher preference by veterinarians, pet owners, and livestock producers and wide applications of this technology are contributing to the large share of the immunodiagnostics segment.

“The companion animal segment dominated the global veterinary diagnostics market in 2020.”
Based on the animal type, the global veterinary diagnostics market is segmented into companion animal and livestock. In 2020, the companion animals segment accounted for the largest share of the global veterinary diagnostics market. This can be attributed to the rising number of companion animals across the globe, the willingness of owners to spend more on their pets, the rising adoption of pet insurance, and the availability of cheaper and easy-to-use POC diagnostic tests for companion animals.

“Veterinary reference laboratories are the major end users in the veterinary diagnostics market.”
Based on end users, the global veterinary diagnostics market is segmented into veterinary reference laboratories, veterinary hospitals and clinics, point-of-care testing/in-house testing, and veterinary research institutes and universities. In 2020, veterinary reference laboratories were the major end users in the veterinary diagnostics market. The large share of the veterinary reference laboratories segment can be attributed to the increasing number of veterinary diagnostic reference laboratories, high test volumes at reference laboratories, and the increasing demand for veterinary diagnostic testing for infectious diseases. Additionally, rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.

“North America accounts for the highest share in the global veterinary diagnostics market in the forecasted period”
North America accounted for the highest share of the global veterinary diagnostics market during the forecast period. The US accounted for the largest share of the North American veterinary diagnostics market in 2020. The growth in the veterinary diagnostics market of North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.

The break of primary participants was as mentioned below:
• By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
• By Designation – C-level–30%, Director-level–50%, Others–20%
• By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%

Key players in the veterinary diagnostics market

The key players in the veterinary diagnostics market include Thermo Fisher Scientific Inc. (US), Zoetis Inc. (US), IDEXX Laboratories Inc. (US), NEOGEN Corporation (US), Bio-Rad Laboratories Inc. (US), bioMérieux SA (France), Virbac (France), Heska Corporation (US), Agrolabo S.p.A. (Italy), INDICAL BIOSCIENCE GmbH (Germany), Randox Laboratories Ltd. (Ireland), IDvet (France), Biopanda Reagents (UK), Bionote, Inc. (South Korea), BioChek (Netherlands), Fassisi GmbH (Germany), Biogal Galed Labs (Israel), Alvedia (France), SKYER, Inc. (South Korea), and Shenzhen Bioeasy Biotechnology Co., Ltd. (China).
Research Coverage:
The report analyzes the veterinary diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, technology, animal type, end user, and region. The report also includes a product portfolio matrix of various veterinary diagnostics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by product, animal type, technology, and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global veterinary diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by product, animal type, technology, and end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global veterinary diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global veterinary diagnostics market.

【レポートの目次】

1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION & SCOPE 54
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 54
1.2.2 MARKETS COVERED 55
1.2.3 YEARS CONSIDERED FOR THE STUDY 56
1.3 CURRENCY 56
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 56
1.4 LIMITATIONS 56
1.5 STAKEHOLDERS 57
1.6 SUMMARY OF CHANGES 57
2 RESEARCH METHODOLOGY 59
2.1 RESEARCH DATA 59
FIGURE 1 RESEARCH DESIGN 59
2.1.1 SECONDARY DATA 59
2.1.1.1 Key data from secondary sources 61
2.1.2 PRIMARY DATA 61
FIGURE 2 PRIMARY SOURCES 61
2.1.2.1 Key data from primary sources 62
2.1.2.2 Key industry insights 63
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (VETERINARY DIAGNOSTICS MARKET) 63
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION 64
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION 64
2.2 MARKET SIZE ESTIMATION 65
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 65
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 66
FIGURE 8 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020) 67
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: LIVESTOCK DIAGNOSTICS MARKET (2020) 68
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY DIAGNOSTICS MARKET (2021–2026) 69
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 69
FIGURE 12 TOP-DOWN APPROACH 70
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 71
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 71
2.4 MARKET SHARE ANALYSIS 72
2.5 ASSUMPTIONS FOR THE STUDY 72
2.6 RISK ASSESSMENT 73
TABLE 2 RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET 73
3 EXECUTIVE SUMMARY 74
FIGURE 14 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 74
FIGURE 15 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 75
FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2021 VS. 2026 (USD MILLION) 75
FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 76
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY DIAGNOSTICS MARKET 77
4 PREMIUM INSIGHTS 78
4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW 78
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH 78
4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020) 79
FIGURE 20 VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR
THE LARGEST SHARE OF THE APAC MARKET IN 2020 79
4.3 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80
FIGURE 21 CHINA TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 80
5 MARKET OVERVIEW 81
5.1 INTRODUCTION 81
5.2 MARKET DYNAMICS 81
FIGURE 22 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81
5.2.1 MARKET DRIVERS 82
5.2.1.1 Growth in the companion animal population 82
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2018 (MILLION) 83
5.2.1.2 Rising demand for animal-derived food products 83
TABLE 4 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES 83
FIGURE 23 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 84
FIGURE 24 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 84
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018 84
5.2.1.3 Increasing incidence of transboundary and zoonotic diseases 85
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 85
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure 86
TABLE 6 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020 86
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019 87
5.2.1.5 Growing number of veterinary practitioners & their rising income levels in developed economies 88
TABLE 7 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018 88
TABLE 8 MARKET DRIVERS: IMPACT ANALYSIS 89
5.2.2 MARKET RESTRAINTS 89
5.2.2.1 Rising pet care costs 89
TABLE 9 MARKET RESTRAINTS: IMPACT ANALYSIS 89
5.2.3 MARKET OPPORTUNITIES 90
5.2.3.1 Increased use of PCR testing panels to rule out COVID-19 virus in animals 90
5.2.3.2 Untapped emerging markets 90
TABLE 10 MARKET OPPORTUNITIES: IMPACT ANALYSIS 91
5.2.4 MARKET CHALLENGES 91
5.2.4.1 Shortage of veterinary practitioners in developing markets 91
TABLE 11 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018 91
TABLE 12 MARKET CHALLENGES: IMPACT ANALYSIS 92
5.3 INDUSTRY TRENDS 92
5.3.1 ADOPTION OF MULTIPLE TESTING PANELS 92
TABLE 13 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS 92
5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 92
5.3.3 GROWING CONSOLIDATION IN THE VETERINARY DIAGNOSTICS INDUSTRY 93
TABLE 14 MAJOR ACQUISITIONS IN THE ANIMAL HEALTH DIAGNOSTICS INDUSTRY 93
5.4 DISEASE TRENDS 94
5.4.1 LIVESTOCK 94
5.4.1.1 Avian influenza (AI) 94
5.4.1.2 African swine fever (ASF) 94
5.4.1.3 Bovine babesiosis (BB) 94
5.4.1.4 Peste des petits ruminants (PPR) 94
5.4.1.5 West Nile virus (WNV) 94
5.4.2 COMPANION ANIMALS 94
5.4.2.1 Zoonotic diseases 94
TABLE 15 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS ACROSS THE GLOBE 95
5.4.2.2 Obesity & diabetes 96
5.5 TECHNOLOGICAL ANALYSIS 96
5.5.1 KEY TECHNOLOGY 96
5.5.1.1 Development of portable instruments for POC diagnostic services 96
TABLE 16 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS 96
5.5.2 ADJACENT TECHNOLOGY 96
5.5.2.1 Development of rapid and sensitive veterinary diagnostic kits 96
5.6 PRICING ANALYSIS 97
TABLE 17 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2019 (USD) 97
5.7 IMPACT OF COVID-19 ON THE VETERINARY DIAGNOSTICS MARKET 98
TABLE 18 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS 98
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020 99
5.8 VALUE CHAIN ANALYSIS 99
FIGURE 28 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 100
5.9 ECOSYSTEM MARKET MAP 100
FIGURE 29 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS 101
FIGURE 30 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP 101
5.10 PORTER’S FIVE FORCES ANALYSIS 102
TABLE 19 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 102
5.10.1 THREAT OF NEW ENTRANTS 102
5.10.2 THREAT OF SUBSTITUTES 103
5.10.3 BARGAINING POWER OF SUPPLIERS 103
5.10.4 BARGAINING POWER OF BUYERS 103
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 103
5.11 SUPPLY CHAIN ANALYSIS 104
FIGURE 31 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 105
5.12 REGULATORY ANALYSIS 105
5.12.1 US 105
5.12.2 EUROPE 106
5.13 PATENT ANALYSIS 106
5.13.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS 107
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–MAY 2021) 107
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 107
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2011–MAY 2021) 108
FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2011–MAY 2021) 109
6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT 110
6.1 INTRODUCTION 111
TABLE 20 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
6.2 CONSUMABLES 111
6.2.1 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY DIAGNOSTIC PRODUCTS MARKET IN 2020 111
TABLE 21 KEY VETERINARY DIAGNOSTIC CONSUMABLES AVAILABLE IN THE MARKET (2020) 112
TABLE 22 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
6.3 INSTRUMENTS 113
6.3.1 INCREASE IN POINT-OF-CARE APPLICATIONS FOR EARLY DIAGNOSIS AND PRECISION IN LIVESTOCK FARMING TO DRIVE MARKET GROWTH 113
TABLE 23 KEY VETERINARY DIAGNOSTIC INSTRUMENTS AVAILABLE IN THE MARKET (2020) 114
TABLE 24 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 115
7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY 116
7.1 INTRODUCTION 117
TABLE 25 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 117
TABLE 26 VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 118
7.1.1 IMPACT OF COVID-19 ON THE TYPE OF TECHNOLOGIES USED 118
7.2 IMMUNODIAGNOSTICS 119
TABLE 27 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET 119
TABLE 28 VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 120
TABLE 29 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 121
7.2.1 LATERAL FLOW ASSAYS 121
TABLE 30 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 31 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
TABLE 32 LATERAL FLOW ASSAYS MARKET, BY REGION, 2019–2026 (MILLION UNITS) 123
7.2.1.1 Lateral flow rapid tests 123
7.2.1.1.1 Lateral flow rapid tests held the larger share of the lateral flow assays market 123
TABLE 33 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.1.2 Lateral flow strip readers 124
7.2.1.2.1 Lateral flow strip readers determine the quantity of analytes in the sample 124
TABLE 34 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.2.2 ELISA TESTS 125
7.2.2.1 ELISA tests are quick, simple to perform, and cost-effective 125
TABLE 35 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 36 ELISA TESTS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 126
7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 127
7.2.3.1 Increasing incidence of allergic diseases in companion animals to drive market growth 127
TABLE 37 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
7.2.4 IMMUNOASSAY ANALYZERS 128
7.2.4.1 Immunoassay analyzers are widely used for livestock 128
TABLE 38 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.2.5 OTHER IMMUNODIAGNOSTIC PRODUCTS 129
TABLE 39 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.3 CLINICAL BIOCHEMISTRY 130
TABLE 40 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN THE MARKET 130
TABLE 41 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 42 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
7.3.1 CLINICAL CHEMISTRY ANALYSIS 132
TABLE 43 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 132
TABLE 44 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
7.3.1.1 Clinical chemistry reagent clips and cartridges 133
7.3.1.1.1 Increasing pet healthcare expenditure and the rising number of screening tests performed to drive market growth 133
TABLE 45 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 134
7.3.1.2 Clinical chemistry analyzers 134
7.3.1.2.1 Increasing installations of clinical chemistry analyzers to drive market growth 134
TABLE 46 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.3.2 GLUCOSE MONITORING 135
TABLE 47 GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 136
TABLE 48 GLUCOSE MONITORING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.3.2.1 Blood glucose strips 137
7.3.2.1.1 Blood glucose strips accounted for the largest share of the glucose monitoring market in 2020 137
TABLE 49 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 137
7.3.2.2 Glucose monitors 138
7.3.2.2.1 Increasing incidence of diabetes in pet animals to drive the adoption of glucose monitors 138
TABLE 50 GLUCOSE MONITORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 138
7.3.2.3 Urine glucose strips 139
7.3.2.3.1 Increasing risk of developing DKA in animals to drive the market growth 139
TABLE 51 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS 140
TABLE 52 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 140
TABLE 53 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 140
7.3.3.1 Blood gas and electrolyte reagent clips and cartridges 141
7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to support market growth 141
TABLE 54 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 141
7.3.3.2 Blood gas & electrolyte analyzers 142
7.3.3.2.1 Blood gas and electrolyte analyzers are used to determine the amount of oxygen and carbon dioxide in the blood 142
TABLE 55 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
7.4 MOLECULAR DIAGNOSTICS 143
TABLE 56 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 57 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
7.4.1 POLYMERASE CHAIN REACTION (PCR) TESTS 144
7.4.1.1 Increased laboratory usage of PCR in proteomics and genomics to support market growth 144
TABLE 58 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
7.4.2 MICROARRAYS 145
7.4.2.1 Growing applications of biochips in the identification of infectious diseases to propel market growth 145
TABLE 59 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 146
7.4.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 146
TABLE 60 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
7.5 HEMATOLOGY 147
TABLE 61 KEY VETERINARY HEMATOLOGY PRODUCTS AVAILABLE IN THE MARKET 148
TABLE 62 VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 148
TABLE 63 VETERINARY HEMATOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
7.5.1 HEMATOLOGY CARTRIDGES 149
7.5.1.1 Hematology cartridges are used along with hematology analyzers for complete blood analysis 149
TABLE 64 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
7.5.2 HEMATOLOGY ANALYZERS 150
7.5.2.1 70% of veterinary hospitals and clinics are equipped with hematology analyzers as a basic diagnostic tool 150
TABLE 65 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 151
TABLE 66 HEMATOLOGY ANALYZERS MARKET, BY REGION, 2019–2026 (UNITS) 151
7.6 URINALYSIS 152
TABLE 67 KEY VETERINARY URINALYSIS PRODUCTS AVAILABLE IN THE MARKET 152
TABLE 68 VETERINARY URINALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 152
TABLE 69 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 153
7.6.1 URINALYSIS CLIPS & CARTRIDGES/PANELS 153
7.6.1.1 Clips and cartridges are used in urine analyzers to detect single or multiple electrolytes or metabolites 153
TABLE 70 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 154
7.6.2 URINE ANALYZERS 154
7.6.2.1 Development of easy-to-use urine analyzers for POC testing to drive market growth 154
TABLE 71 URINE ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 155
7.6.3 URINE TEST STRIPS 155
7.6.3.1 Rising occurrence of kidney diseases in cats and dogs to support the market growth 155
TABLE 72 URINE TEST STRIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
7.7 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES 156
TABLE 73 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE 158
8.1 INTRODUCTION 159
TABLE 74 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 159
8.2 COMPANION ANIMALS 159
FIGURE 35 MARKET FOR DOGS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 160
TABLE 75 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 76 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION) 161
8.2.1 DOGS 161
8.2.1.1 Dogs dominate the veterinary diagnostics market for companion animals 161
TABLE 77 DOG POPULATION, BY COUNTRY, 2012–2019 (MILLION) 162
TABLE 78 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY,
2019–2026 (USD MILLION) 162
8.2.2 CATS 163
8.2.2.1 Increasing pet cat population to drive market growth 163
TABLE 79 CAT POPULATION, BY COUNTRY, 2012–2019 (MILLION) 163
TABLE 80 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY,
2019–2026 (USD MILLION) 164
8.2.3 HORSES 164
8.2.3.1 Growing equine health awareness to drive market growth 164
TABLE 81 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND) 165
TABLE 82 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY,
2019–2026 (USD MILLION) 166
8.2.4 OTHER COMPANION ANIMALS 166
TABLE 83 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION) 167
8.3 LIVESTOCK 167
TABLE 84 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 168
FIGURE 36 MARKET FOR CATTLE TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 169
TABLE 85 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY,
2019–2026 (USD MILLION) 169
8.3.1 CATTLE 170
8.3.1.1 Growing consumption of meat to support market growth 170
TABLE 86 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 170
TABLE 87 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY,
2019–2026 (USD MILLION) 171
8.3.2 PIGS 171
8.3.2.1 Growing incidence of infectious diseases to drive market growth 171
TABLE 88 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 172
FIGURE 37 PER CAPITA PORK CONSUMPTION, 2006–2018 (POUNDS) 172
TABLE 89 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY,
2019–2026 (USD MILLION) 173
8.3.3 POULTRY 173
8.3.3.1 Increasing demand for poultry meat to support the growth of the diagnostics market 173
FIGURE 38 PER CAPITA POULTRY MEAT CONSUMPTION, 2006–2018 (POUNDS) 174
TABLE 90 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION) 174
TABLE 91 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY,
2019–2026 (USD MILLION) 175
8.3.4 OTHER LIVESTOCK 175
TABLE 92 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION) 176
9 VETERINARY DIAGNOSTICS MARKET, BY END USER 177
9.1 INTRODUCTION 178
TABLE 93 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 178
9.2 VETERINARY REFERENCE LABORATORIES 178
9.2.1 VETERINARY REFERENCE LABORATORIES ARE THE LARGEST END USERS OF VETERINARY DIAGNOSTICS 178
TABLE 94 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 179
9.3 VETERINARY HOSPITALS & CLINICS 179
9.3.1 INCREASING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH 179
TABLE 95 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 180
9.4 POINT-OF-CARE/IN-HOUSE TESTING 180
9.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS 180
TABLE 96 VETERINARY DIAGNOSTICS MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 181
9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 182
9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH 182
TABLE 97 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION) 183
10 VETERINARY DIAGNOSTICS MARKET, BY REGION 184
10.1 INTRODUCTION 185
TABLE 98 VETERINARY DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION) 185
10.2 NORTH AMERICA 185
FIGURE 39 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA 186
FIGURE 40 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 187
TABLE 99 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
TABLE 100 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 188
TABLE 101 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 188
TABLE 102 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 188
TABLE 103 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 104 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 105 NORTH AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 189
TABLE 106 NORTH AMERICA: VETERINARY GLUCOSE MONITORING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 107 NORTH AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 108 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 109 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 191
TABLE 110 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 191
TABLE 111 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 191
TABLE 112 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 113 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,
BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 114 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 192
10.2.1 US 193
10.2.1.1 The US dominated the North American veterinary diagnostics market in 2020 193
FIGURE 41 US: DOGS POPULATION, 2012–2020 (MILLION) 193
FIGURE 42 US: EXPENDITURE ON VET VISITS 193
TABLE 115 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 194
FIGURE 43 NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 IN THE US, 2020 194
FIGURE 44 NUMBER OF VETERINARIANS IN THE US, 2014–2019 195
TABLE 116 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES,
2014–2019 195
TABLE 117 US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 196
TABLE 118 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 196
TABLE 119 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 196
TABLE 120 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 121 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 122 US: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 197
TABLE 123 US: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 124 US: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 198
TABLE 125 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 126 US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 127 US: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 128 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 199
TABLE 129 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 130 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 131 US: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 200
10.2.2 CANADA 201
10.2.2.1 Growing pet adoption in Canada to drive market growth 201
FIGURE 45 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 201
TABLE 132 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 201
TABLE 133 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 202
TABLE 134 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 202
TABLE 135 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 136 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 137 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 138 CANADA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 139 CANADA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 140 CANADA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 141 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 205
TABLE 142 CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 205
TABLE 143 CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 205
TABLE 144 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 206
TABLE 145 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 146 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 147 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 207
10.3 EUROPE 207
TABLE 148 EUROPE: COMPANION POPULATION, 2019 (MILLION) 207
TABLE 149 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION) 208
FIGURE 46 EU-27: LIVESTOCK POPULATION, 2012–2019 (MILLION) 208
TABLE 150 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 209
TABLE 151 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 210
TABLE 152 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 210
TABLE 153 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 210
TABLE 154 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 211
TABLE 155 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 211
TABLE 156 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 211
TABLE 157 EUROPE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 158 EUROPE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 159 EUROPE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 160 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 213
TABLE 161 EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 213
TABLE 162 EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 213
TABLE 163 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 214
TABLE 164 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 165 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 166 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 215
10.3.1 GERMANY 215
10.3.1.1 Rising awareness regarding zoonotic diseases to drive market growth 215
TABLE 167 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 215
TABLE 168 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 216
TABLE 169 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019 216
TABLE 170 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 216
TABLE 171 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 217
TABLE 172 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 217
TABLE 173 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 217
TABLE 174 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 175 GERMANY: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 218
TABLE 176 GERMANY: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 218
TABLE 177 GERMANY: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 219
TABLE 178 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 219
TABLE 179 GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 219
TABLE 180 GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 220
TABLE 181 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 220
TABLE 182 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 183 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 184 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 221
10.3.2 UK 221
10.3.2.1 The UK is the fastest-growing market for veterinary diagnostics in Europe 221
TABLE 185 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION) 222
TABLE 186 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 222
TABLE 187 UK: NUMBER OF VETERINARIANS, 2014 VS. 2019 222
TABLE 188 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 223
TABLE 189 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 223
TABLE 190 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 223
TABLE 191 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 224
TABLE 192 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 193 UK: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 224
TABLE 194 UK: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 225
TABLE 195 UK: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 225
TABLE 196 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 225
TABLE 197 UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 226
TABLE 198 UK: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 226
TABLE 199 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 226
TABLE 200 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 201 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 202 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 227
10.3.3 FRANCE 228
10.3.3.1 France is one of the leading markets for companion pet ownership 228
TABLE 203 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 228
TABLE 204 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 229
TABLE 205 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2017 229
TABLE 206 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 229
TABLE 207 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 230
TABLE 208 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 209 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 210 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 211 FRANCE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 231
TABLE 212 FRANCE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 231
TABLE 213 FRANCE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 232
TABLE 214 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 232
TABLE 215 FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 232
TABLE 216 FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 233
TABLE 217 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 233
TABLE 218 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 219 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 220 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 234

10.3.4 ITALY 234
10.3.4.1 Rising awareness about pet healthcare to propel market growth 234
TABLE 221 ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION) 235
TABLE 222 ITALY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 235
TABLE 223 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2019 235
TABLE 224 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 236
TABLE 225 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 236
TABLE 226 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 236
TABLE 227 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 237
TABLE 228 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 229 ITALY: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 237
TABLE 230 ITALY: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 238
TABLE 231 ITALY: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 238
TABLE 232 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 238
TABLE 233 ITALY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 239
TABLE 234 ITALY: VETERINARY URINALYSIS MARKET, BY TYPE,
2019–2026 (USD MILLION) 239
TABLE 235 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 239
TABLE 236 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 237 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 240
TABLE 238 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 240
10.3.5 SPAIN 241
10.3.5.1 Growing demand for pig and poultry products to aid the adoption of veterinary diagnostic products 241
TABLE 239 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 241
TABLE 240 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 242
TABLE 241 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 242
TABLE 242 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 242
TABLE 243 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 243
TABLE 244 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 243
TABLE 245 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 243
TABLE 246 SPAIN: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 244
TABLE 247 SPAIN: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 244
TABLE 248 SPAIN: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 244
TABLE 249 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 245
TABLE 250 SPAIN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 245
TABLE 251 SPAIN: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 245
TABLE 252 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 246
TABLE 253 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 246
TABLE 254 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 246
TABLE 255 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 247
10.3.6 REST OF EUROPE 247
TABLE 256 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION) 247
TABLE 257 ROE: LIVESTOCK POPULATION, BY COUNTRY, 2019 (MILLION) 248
TABLE 258 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
2010 VS. 2019 248
TABLE 259 ROE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 248
TABLE 260 ROE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 249
TABLE 261 ROE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 249
TABLE 262 ROE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 249
TABLE 263 ROE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 250
TABLE 264 ROE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 250
TABLE 265 ROE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 250
TABLE 266 ROE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 251
TABLE 267 ROE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 251
TABLE 268 ROE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 251
TABLE 269 ROE: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 252
TABLE 270 ROE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 252
TABLE 271 ROE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 252
TABLE 272 ROE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 253
TABLE 273 ROE: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 253
10.4 ASIA PACIFIC 253
FIGURE 47 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 254
TABLE 274 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 255
TABLE 275 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 255
TABLE 276 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 255
TABLE 277 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 256
TABLE 278 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 256
TABLE 279 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2019–2026 (USD MILLION) 256
TABLE 280 ASIA PACIFIC: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 257
TABLE 281 ASIA PACIFIC: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 257
TABLE 282 ASIA PACIFIC: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 257
TABLE 283 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 258
TABLE 284 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 258
TABLE 285 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 258
TABLE 286 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 259
TABLE 287 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 288 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 259
TABLE 289 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 260
10.4.1 CHINA 260
10.4.1.1 China dominated the APAC veterinary diagnostics market in 2020 260
TABLE 290 CHINA: LIVESTOCK POPULATION , 2010-2019 (MILLION) 261
TABLE 291 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 261
TABLE 292 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 262
TABLE 293 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 262
TABLE 294 CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 262
TABLE 295 CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 263
TABLE 296 CHINA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 263
TABLE 297 CHINA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 263
TABLE 298 CHINA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 264
TABLE 299 CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 264
TABLE 300 CHINA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 264
TABLE 301 CHINA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 265
TABLE 302 CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 265
TABLE 303 CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 265
TABLE 304 CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 266
TABLE 305 CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 266
10.4.2 JAPAN 266
10.4.2.1 Rising awareness about zoonotic diseases and increased pet expenditure are driving market growth 266
TABLE 306 PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS) 267
TABLE 307 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 267
TABLE 308 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 268
TABLE 309 JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 268
TABLE 310 JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 268
TABLE 311 JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 269
TABLE 312 JAPAN: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 269
TABLE 313 JAPAN: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 269
TABLE 314 JAPAN: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 270
TABLE 315 JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 270
TABLE 316 JAPAN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 270
TABLE 317 JAPAN: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 271
TABLE 318 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 271
TABLE 319 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 271
TABLE 320 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 272
TABLE 321 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 272
10.4.3 INDIA 272
10.4.3.1 India is an untapped market with huge growth potential 272
TABLE 322 INDIA: LIVESTOCK POPULATION, 2007-2019 (MILLION) 273
TABLE 323 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 273
TABLE 324 INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 273
TABLE 325 INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 274
TABLE 326 INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 274
TABLE 327 INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 274
TABLE 328 INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 275
TABLE 329 INDIA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 275
TABLE 330 INDIA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 275
TABLE 331 INDIA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 276
TABLE 332 INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 276
TABLE 333 INDIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 276
TABLE 334 INDIA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 277
TABLE 335 INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 277
TABLE 336 INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 277
TABLE 337 INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 278
TABLE 338 INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 278
10.4.4 REST OF APAC 278
TABLE 339 ROAPAC: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION) 279
TABLE 340 ROAPAC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 280
TABLE 341 ROAPAC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 280
TABLE 342 ROAPAC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 280
TABLE 343 ROAPAC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 281
TABLE 344 ROAPAC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 281
TABLE 345 ROAPAC: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 281
TABLE 346 ROAPAC: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 282
TABLE 347 ROAPAC: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 282
TABLE 348 ROAPAC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 282
TABLE 349 ROAPAC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 283
TABLE 350 ROAPAC: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 283
TABLE 351 ROAPAC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 283
TABLE 352 ROAPAC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 353 ROAPAC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 284
TABLE 354 ROAPAC: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 284
10.5 LATIN AMERICA 285
TABLE 355 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY,
2010-2019 (MILLION) 285
TABLE 356 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019 286
TABLE 357 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 286
TABLE 358 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 286
TABLE 359 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 287
TABLE 360 LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 287
TABLE 361 LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2019–2026 (USD MILLION) 287
TABLE 362 LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2019–2026 (USD MILLION) 288
TABLE 363 LATIN AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 288
TABLE 364 LATIN AMERICA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 288
TABLE 365 LATIN AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 289
TABLE 366 LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 289
TABLE 367 LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 289
TABLE 368 LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 290
TABLE 369 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 290
TABLE 370 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 290
TABLE 371 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,
BY TYPE, 2019–2026 (USD MILLION) 291
TABLE 372 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 291
10.5.1 BRAZIL 291
10.5.1.1 Brazil has the fourth-largest pet population in the world 291
TABLE 373 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 292
TABLE 374 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 292
TABLE 375 BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 293
TABLE 376 BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 293
TABLE 377 BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 293
TABLE 378 BRAZIL: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 294
TABLE 379 BRAZIL: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 294
TABLE 380 BRAZIL: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 294
TABLE 381 BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 295
TABLE 382 BRAZIL: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 295
TABLE 383 BRAZIL: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 295
TABLE 384 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 296
TABLE 385 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 296
TABLE 386 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 296
TABLE 387 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 297
10.5.2 MEXICO 297
10.5.2.1 Mexico is the second-largest pet care market in Latin America 297
TABLE 388 MEXICO: LIVESTOCK POPULATION, 2010–2019 (MILLION) 297
TABLE 389 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 298
TABLE 390 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 298
TABLE 391 MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 298
TABLE 392 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 299
TABLE 393 MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 299
TABLE 394 MEXICO: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 299
TABLE 395 MEXICO: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 300
TABLE 396 MEXICO: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 300
TABLE 397 MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 300
TABLE 398 MEXICO: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 301
TABLE 399 MEXICO: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 301
TABLE 400 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 301
TABLE 401 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 302
TABLE 402 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 302
TABLE 403 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 302
10.5.3 REST OF LATIN AMERICA 303
TABLE 404 ROLATAM: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 303
TABLE 405 ROLATAM: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 304
TABLE 406 ROLATAM: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 304
TABLE 407 ROLATAM: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 304
TABLE 408 ROLATAM: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 305
TABLE 409 ROLATAM: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 305
TABLE 410 ROLATAM: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 305
TABLE 411 ROLATAM: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 306
TABLE 412 ROLATAM: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 306
TABLE 413 ROLATAM: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 306
TABLE 414 ROLATAM: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 307
TABLE 415 ROLATAM: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 307
TABLE 416 ROLATAM: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 307
TABLE 417 ROLATAM: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 308
TABLE 418 ROLATAM: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 308
10.6 MIDDLE EAST & AFRICA 308
10.6.1 MIDDLE EAST & AFRICA IS AN EMERGING MARKET FOR ANIMAL HEALTHCARE 308
TABLE 419 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION) 309
TABLE 420 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018 309
TABLE 421 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION) 309
TABLE 422 AFRICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
2010–2018 310
TABLE 423 MEA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 310
TABLE 424 MEA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 310
TABLE 425 MEA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 311
TABLE 426 MEA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 311
TABLE 427 MEA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 311
TABLE 428 MEA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 312
TABLE 429 MEA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 312
TABLE 430 MEA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 312
TABLE 431 MEA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 313
TABLE 432 MEA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 313
TABLE 433 MEA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 313
TABLE 434 MEA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 314
TABLE 435 MEA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 314
TABLE 436 MEA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 314
TABLE 437 MEA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 315
11 COMPETITIVE LANDSCAPE 316
11.1 OVERVIEW 316
11.2 KEY PLAYER STRATEGIES 316
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 317
FIGURE 48 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE VETERINARY DIAGNOSTICS MARKET 317
11.4 MARKET SHARE ANALYSIS 318
FIGURE 49 VETERINARY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2020 318
11.5 COMPANY EVALUATION QUADRANT 319
11.5.1 STARS 320
11.5.2 EMERGING LEADERS 320
11.5.3 PERVASIVE PLAYERS 320
11.5.4 PARTICIPANTS 320
FIGURE 50 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT (2020) 321
11.6 COMPANY EVALUATION QUADRANT FOR STARTUPS 322
11.6.1 PROGRESSIVE COMPANIES 322
11.6.2 DYNAMIC COMPANIES 322
11.6.3 STARTING BLOCKS 322
11.6.4 RESPONSIVE COMPANIES 322
FIGURE 51 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS (2020) 323
11.7 COMPANY PRODUCT FOOTPRINT 324
TABLE 438 PRODUCT PORTFOLIO ANALYSIS: VETERINARY DIAGNOSTICS MARKET 324
11.8 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS 325
TABLE 439 TECHNOLOGY FOOTPRINT: VETERINARY DIAGNOSTICS MARKET (2020) 325
11.9 END-USER FOOTPRINT OF MAJOR PLAYERS 326
TABLE 440 END-USER FOOTPRINT: VETERINARY DIAGNOSTICS MARKET (2020) 326
11.10 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS 327
TABLE 441 GEOGRAPHIC FOOTPRINT: VETERINARY DIAGNOSTICS MARKET (2020) 327
11.11 COMPETITIVE SCENARIO 328
TABLE 442 PRODUCT LAUNCHES, 2018–2021 328
TABLE 443 DEALS, 2018–2021 328
TABLE 444 OTHER DEVELOPMENTS, 2018–2021 330
12 COMPANY PROFILES 331
12.1 KEY PLAYERS 331
(Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
12.1.1 IDEXX LABORATORIES, INC. 331
TABLE 445 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW 331
FIGURE 52 IDEXX LABORATORIES: COMPANY SNAPSHOT (2020) 332
12.1.2 ZOETIS, INC. 340
TABLE 446 ZOETIS, INC.: BUSINESS OVERVIEW 340
FIGURE 53 ZOETIS, INC.: COMPANY SNAPSHOT (2020) 341
12.1.3 THERMO FISHER SCIENTIFIC, INC. 347
TABLE 447 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 347
FIGURE 54 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 348
12.1.4 HESKA CORPORATION 360
TABLE 448 HESKA CORPORATION: BUSINESS OVERVIEW 360
FIGURE 55 HESKA CORPORATION: COMPANY SNAPSHOT (2020) 360
12.1.5 BIOMÉRIEUX SA 363
TABLE 449 BIOMÉRIEUX SA: BUSINESS OVERVIEW 363
FIGURE 56 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020) 364
12.1.6 NEOGEN CORPORATION 369
TABLE 450 NEOGEN CORPORATION: BUSINESS OVERVIEW 369
FIGURE 57 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020) 370
12.1.7 BIO-RAD LABORATORIES, INC. 375
TABLE 451 BIO-RAD LABORATORIES: BUSINESS OVERVIEW 375
FIGURE 58 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 376
12.1.8 VIRBAC 379
TABLE 452 VIRBAC: BUSINESS OVERVIEW 379
FIGURE 59 VIRBAC: COMPANY SNAPSHOT (2020) 379
12.1.9 INDICAL BIOSCIENCE GMBH 382
TABLE 453 INDICAL BIOSCIENCE GMBH 382
12.1.10 BIONOTE INC. 385
TABLE 454 BIONOTE INC.: BUSINESS OVERVIEW 385
12.1.11 BIOGAL GALED LABS 387
TABLE 455 BIOGAL GALED LABS: BUSINESS OVERVIEW 387
12.1.12 AGROLABO S.P.A. 389
TABLE 456 AGROLABO S.P.A.: BUSINESS OVERVIEW 389
12.1.13 IDVET 399
TABLE 457 IDVET: BUSINESS OVERVIEW 399
12.1.14 RANDOX LABORATORIES LTD. 406
TABLE 458 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW 406
12.1.15 BIOCHEK 408
TABLE 459 BIOCHEK: BUSINESS OVERVIEW 408
12.2 OTHER PLAYERS 412
12.2.1 FASSISI GMBH 412
TABLE 460 FASSISI GMBH: BUSINESS OVERVIEW 412
12.2.2 ALVEDIA 414
TABLE 461 ALVEDIA: BUSINESS OVERVIEW 414
12.2.3 SKYER, INC. 416
TABLE 462 SKYER, INC.: BUSINESS OVERVIEW 416
12.2.4 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 418
TABLE 463 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 418
12.2.5 BIOPANDA REAGENTS 420
TABLE 464 BIOPANDA REAGENTS: BUSINESS OVERVIEW 420
*Business Overview, Products/Solutions Offered, Recent Developments, SWOT Analysis, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.

13 APPENDIX 422
13.1 DISCUSSION GUIDE 422
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 428
13.3 AVAILABLE CUSTOMIZATIONS 430
13.4 RELATED REPORTS 430
13.5 AUTHOR DETAILS 431

★調査レポート[世界の動物診断市場予測:製品別、技術別、動物別、エンドユーザー別] ( Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2026 / MD2411) 販売に関する免責事項
[世界の動物診断市場予測:製品別、技術別、動物別、エンドユーザー別] ( Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2026 / MD2411) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆